Skip navigation

Disease Brain Diseases

These diseases have comparable sets of interacting chemicals and genes to Brain Diseases.

Via chemical associations

Similarity Index Common
Interacting
Chemicals
Nervous System Diseases 0.19865 0.19865 88
Brain Injuries 0.17647 0.17647 57
Coma 0.16573 0.16573 59
Confusion 0.1612 0.1612 59
Cognition Disorders 0.15824 0.15824 72
Nerve Degeneration 0.1567 0.1567 76
Ataxia 0.15561 0.15561 61
Central Nervous System Diseases 0.15506 0.15506 49
Vision Disorders 0.15432 0.15432 50
Renal Insufficiency 0.15091 0.15091 75
Movement Disorders 0.15 0.15 66
Memory Disorders 0.14695 0.14695 77
Neurotoxicity Syndromes 0.14684 0.14684 58
Peripheral Nervous System Diseases 0.14528 0.14528 60
Status Epilepticus 0.14525 0.14525 52
Hallucinations 0.14524 0.14524 61
Psychoses, Substance-Induced 0.14521 0.14521 53
Vomiting 0.1445 0.1445 88
Drug-Related Side Effects and Adverse Reactions 0.14245 0.14245 100
Epilepsy, Tonic-Clonic 0.13889 0.13889 45

Via marker/mechanism chemical associations

Similarity Index Common
Interacting
Chemicals
Nervous System Diseases 0.19789 0.19789 75
Cognition Disorders 0.17429 0.17429 61
Coma 0.16199 0.16199 52
Nerve Degeneration 0.15942 0.15942 55
Memory Disorders 0.15934 0.15934 58
Neurotoxicity Syndromes 0.15854 0.15854 52
Central Nervous System Diseases 0.15714 0.15714 44
Confusion 0.1568 0.1568 53
Learning Disorders 0.15361 0.15361 49
Fever 0.15222 0.15222 65
Renal Insufficiency 0.14612 0.14612 64
Brain Injuries 0.14286 0.14286 36
Drug-Related Side Effects and Adverse Reactions 0.1426 0.1426 80
Peripheral Nervous System Diseases 0.14245 0.14245 50
Vision Disorders 0.14094 0.14094 42
Vomiting 0.14048 0.14048 76
Movement Disorders 0.14045 0.14045 50
Ataxia 0.14006 0.14006 50
Muscle Weakness 0.14 0.14 42
Thrombocytopenia 0.13984 0.13984 53

Via therapeutic chemical associations

Similarity Index Common
Interacting
Chemicals
Cataract 0.125 0.125 6
Movement Disorders 0.10156 0.10156 13
Alcohol Withdrawal Delirium 0.1 0.1 4
Dystonia 0.1 0.1 8
Muscle Cramp 0.09804 0.09804 5
Prenatal Exposure Delayed Effects 0.09804 0.09804 5
Paresis 0.09524 0.09524 4
Muscle Rigidity 0.09375 0.09375 9
Drug-Related Side Effects and Adverse Reactions 0.08889 0.08889 16
Basal Ganglia Diseases 0.08772 0.08772 5
Catatonia 0.08571 0.08571 6
Confusion 0.08511 0.08511 4
Hypokinesia 0.08434 0.08434 7
Amyotrophic Lateral Sclerosis 0.08333 0.08333 4
Brain Injuries 0.08333 0.08333 8
Cardiovascular Abnormalities 0.08333 0.08333 3
Speech Disorders 0.08333 0.08333 3
Neural Tube Defects 0.08 0.08 4
Brain Infarction 0.07843 0.07843 4
Coma 0.07843 0.07843 4

Via gene associations

Similarity Index Common
Interacting
Genes
Tuberous Sclerosis 0.12 0.12 3
Cognition Disorders 0.09091 0.09091 5
Occupational Diseases 0.09091 0.09091 3
Epilepsy 0.08974 0.08974 7
Nerve Degeneration 0.08333 0.08333 9
Trichuriasis 0.08 0.08 2
Tuberous Sclerosis 2 0.08 0.08 2
Urticaria 0.07895 0.07895 3
Focal cortical dysplasia of Taylor 0.07692 0.07692 2
Hyperammonemia 0.07143 0.07143 2
Lymphangioleiomyomatosis 0.07143 0.07143 2
Respiratory Tract Diseases 0.06897 0.06897 2
Spasms, Infantile 0.06897 0.06897 2
Dementia 0.06452 0.06452 2
Arthritis, Experimental 0.0625 0.0625 4
Pleural Diseases 0.06061 0.06061 2
Heart Diseases 0.05882 0.05882 4
Hyperplasia 0.05882 0.05882 3
Pulmonary Emphysema 0.05882 0.05882 2
Hepatitis B 0.05556 0.05556 3

Via marker/mechanism gene associations

Similarity Index Common
Interacting
Genes
Epilepsy 0.10145 0.10145 7
Cognition Disorders 0.1 0.1 5
Occupational Diseases 0.09677 0.09677 3
Tuberous Sclerosis 0.08696 0.08696 2
Focal cortical dysplasia of Taylor 0.08333 0.08333 2
Urticaria 0.08333 0.08333 3
Nerve Degeneration 0.07792 0.07792 6
Hyperammonemia 0.07692 0.07692 2
Lymphangioleiomyomatosis 0.07692 0.07692 2
Spasms, Infantile 0.07407 0.07407 2
Dementia 0.06897 0.06897 2
Hyperplasia 0.06667 0.06667 3
Arthritis, Experimental 0.05263 0.05263 3
Liver Failure, Acute 0.05263 0.05263 2
Retinal Degeneration 0.05263 0.05263 2
Hepatitis, Chronic 0.04762 0.04762 2
Nephrotic Syndrome 0.04762 0.04762 2
Developmental Disabilities 0.04545 0.04545 2
Seizures 0.04505 0.04505 5
Amyloidosis, Cerebroarterial, App-Related 0.04348 0.04348 1
Camurati-Engelmann Syndrome 0.04348 0.04348 1
Cholestasis, Extrahepatic 0.04348 0.04348 2
Cognitive Dysfunction 0.04348 0.04348 1
CORTICAL MALFORMATIONS, OCCIPITAL 0.04348 0.04348 1
Dicarboxylicaminoaciduria 0.04348 0.04348 1
Epilepsy, Benign Neonatal 0.04348 0.04348 1
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7 0.04348 0.04348 1
Gastric Antral Vascular Ectasia 0.04348 0.04348 1
HIV Seropositivity 0.04348 0.04348 1
Hypersensitivity, Delayed 0.04348 0.04348 1
Hyperthyroxinemia, Familial Dysalbuminemic 0.04348 0.04348 1
Leukoencephalopathy, Cystic, Without Megalencephaly 0.04348 0.04348 1
Low Tension Glaucoma 0.04348 0.04348 1
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME 0.04348 0.04348 1
Myeloperoxidase Deficiency 0.04348 0.04348 1
Opisthorchiasis 0.04348 0.04348 1
Ornithine Carbamoyltransferase Deficiency Disease 0.04348 0.04348 1
ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO 0.04348 0.04348 1
Penile Induration 0.04348 0.04348 1
Peritoneal Fibrosis 0.04348 0.04348 1
Posterior Leukoencephalopathy Syndrome 0.04348 0.04348 1
Rhinitis, Allergic, Perennial 0.04348 0.04348 1
SEIZURES, BENIGN FAMILIAL NEONATAL, 1 0.04348 0.04348 1
Serum Sickness 0.04348 0.04348 1
Tuberous Sclerosis 1 0.04348 0.04348 1
Vasculopathy, Retinal, With Cerebral Leukodystrophy 0.04348 0.04348 1
ZINC, ELEVATED PLASMA 0.04348 0.04348 1

Via therapeutic gene associations